EU Regulators Concerned By Mushrooming Of Small COVID-19 Trials

Want Better Use Of The Short Window Of Opportunity

 
• By Vibha Sharma

Based on experience from earlier epidemics, EU regulators are concerned that the high number of COVID-19 trials starting in a confined geography at the peak of the coronavirus pandemic will not be able to enrol patients up to their pre-established sample size. 

Coronavirus
Small, individual COVID-19 Trials May Not Generate Conclusive Evidence • Source: Shutterstock

More from Clinical Trials

More from R&D